Endo Y, Kato M, Kitoh A, Kore-eda S, Fukuda S, Hashimoto T, Toda K, Miyachi Y, Utani A:Pemphigoid without mucous involvement showing autoantibodies against laminin-332 Gamma 2 subunit.Br J Dermatol. 2010 Jun 25. [Epub ahead of print]
Hasegawa M, Matsusita Y, Horikawa M, Higashi K, Tomigahara Y, Kaneko H, Shirasaki F, Fujimoto m, Takehara k, Sato S:A novel inhibitor of Smad-dependent transcriptional activation suppresses tissue fibrosis in mouse models of systemic sclerosis.ACR 60(11): 3465-3475, 2009
Endo Y, Tsujioka K, Tanioka M, Minegaki Y, Ohyama B, Hashimoto T, Miyachi Y, Utani A:Bullous dermatosis associated with IgG antibodies specific for desmocollins.Eur J Dermatol 20(5); 1-6, 2010
Utani A:Two cases of blaschkitis with prominent pigmentation.J Dermatol 37(8)751-754, 2010
Yamamoto Y, Tanioka M, Hayashino Y, Mishina H, Kato M, Fukuhara S, Utani A, Miyachi Y:Application of a two-question screening instrument to detect depressive symptoms in patients with vitiligo : A pilot study.J Am Acad Dermatol [in press]
yoshizaki A, Yanaba K, Iwata Y, Komura K, Ogawa A, Akiyama Y, Muroi E, Hara T, Ogawa F, Takenaka M, Shimizu K, Hasegawa M, Fujimoto M, T fF Tedder, Sato S:Cell adhesion molecules regulate fibrotic process via Th1/Th2/Th17 cell balance in a bleomycin-induced scleroderma model.J Immunol 185( ): - , 2010
Murata I, Hayashi M, Hozumi Y, Fujii K, Mitsuhashi Y, Oiso N, Fukai K, Kuroki N, Mori Y, Utani A, Tomita Y, Fujita Y, Suzuki T:Mutation analyses of patients with dyschromatosis symmetrica hereditaria: Five novel mutations of the ADAR1 gene.Journal of Dermatological Science 58(3): 218-220
Nakahigashi K, Kabashima K, Akiyama H, Utani A, Miyachi Y:Refractory cutaneous lichenoid sarcoidosis treated with tranilast.J Am Acad Dermatol 63(1): 171-172, 2010
Koike Y, Muroi E, Yoshizaki A, Ogawa F, Yanaba K, Takenaka M, Shimizu K, Sato S:Autoantibody against survivin in patients with systemic sclerosis.J Rheumatol 2010 Jun 15[Epub ahead of print]
Muroi E, Hara T, Yanaba K, Ogawa F, Yoshizaki A, Takenaka m, Shimizu K, Sato S:A portable dermatoscope for easy, rapid examination of periungual nailfold capillary changes in patients wuth syatemic sclerosis.Rheumatol Int. 2010 May 27 [Epub ahead of print]
Yoshizaki A, Yanaba K, Yoshizaki As, Iwata Y, Komura K, Ogawa F, Takenaka M, Shimizu K, Asano Y, Hasegawa M, Fujimoto M, Sato S.:Treatment with rapamycin prevents fibrosis in tight-skin and bleomycin-induced mouse models of systemic sclerosis.Arthritis Rheum. 2010 Apr 6. [Epub ahead of print]
Yanaba K, Yoshizaki A, Muroi E, Hara T, Ogawa F, Shimizu K, Sato S:The proteasome inhibitor bortezomib inhibits T cell-dependent inflammatory responses.J Leukoc Biol 88(1): 117-122, 2010
Tomita H, Ogawa F, Hara T, Yanaba K, Iwata Y, Muroi E, Yoshizaki A, Komura K, Takenaka M, Shimizu K, Hasegawa M, Fujimoto M, Sato S:Elevated serum concentrations of triggering receptor expressed on myeloid cells-1 in diffuse cutaneous systemic sclerosis: Association with severity of pulmonary fibrosis.J Rheumatol 37(4): 787-791, 2010
Bae SJ, Lee JB, Shimizu K, Kuwazuka Y.:Increase effect of transforming growth factor on eotaxin production by normal cultured dermal fibroblasts stimulated with interleukin-4: inhibitory effect of suplatast tosilate on eotaxin production.Immunol Invest 39(2): 93-102, 2010
Hori M, Suzuki K, Udono MU, Yamauchi M, Mine M, Watanabe M, Kondo S, Hozumi Y:Establishment of ponasterone A-inducible the wild-type p53 protein-expressing clones from HSC-1 cells, cell growth suppression by p53 expression and the suppression mechanism.Arch Dermatol Res 301(9): 631-646, 2009"
Yoshizaki A, Nakayama T, Naito S, Sekine I:Expression patterns of angiopoietin-1, -2, and tie-2 receptor in ulcerative colitis support involvement of the angiopoietin/tie pathway in the progression of ulcerative colitis.Dig Dis Sci 54(10): 2094-2099, 2009
Muroi E, Ogawa F, Yamaoka T, Sueyoshi F, Sato S:Case of localized scleroderma associated with osteomyelitis.J Dermatol 37(1): 81-84, 2010
Ogawa F, Shimizu K, Hara T, Muroi E, Komura K, Takenaka M, Hasegawa M, Fujimoto M, Takehara K, Sato S:Autoantibody against one of the antioxidant repair enzymes, methionine sulfoxide reductase A, in systemic sclerosis: Association with pulmonary fibrosis and vascular damage.Arch Dermatol Res 302(1): 27-35, 2010
Hara T, Shimizu K, Ogawa F, Yanaba K, Iwata Y, Muroi E, Takenaka M, komura K, Sato S:Platelets control leukocyte recruitment in a murine model of cutaneous arthus reaction.Am J Pathol 176(1): 259-269, 2010
Yanaba K, Yoshizaki A, Muroi E, Hara T, Ogawa F, Shimizu K, Hasegawa M, Fujimoto M, Takehara K, Sato S:CCL13 is a promising diagnostic marker for systemic sclerosis.Br J Dermatol 162: 332-336, 2010
Bae SJ, Shimizu K, Yozaki M, Yamaoka T, Akiyama Y, Yoshizaki A, Muroi E, Hara T, Ogawa F, Sato S:Involvement of L-selectin in contact hypersensitivity responses augmented by auditory stress.Am J Pathol 176(1): 187-197, 2010
Ishikawa H, Bae SangJae, Katayama I:Human β-Defensin-2 expression by keratinocytes is induced by Co-culture with rycophyton rubrum through toll-like receptors 2 and 4.The Open Dermatology Journal: 3 81-85, 2009
Yanaba K, Yoshizaki A, Muroi E, Hara T, Ogawa F, Shimizu k, Sato S:The proteasome inhibitor bortezomib inhibits contact hypersensitivity.Am J Pathol, [in press]
Tomita H, Iwata Y, Ogawa F, Komura K, Shimizu K, Yoshizaki A, Hara T, Muroi E, Yanaba K, Bae SJ, Takenaka M, Hasegawa M, Fujimoto M, Sato S:P-selectin glycoprotein ligand-1 contributes to wound healing predominantly as a p-selectin ligand and partly as an e-selectin ligand..J Invest Dermatol 129(8): 2059-2067, 2009
Okazaki S, Ogawa F, Iwata Y, Hara T, Muroi E, Komura K, Takenaka M, Shimizu K, Hasegawa M, Fujimoto M, Sato S:Autoantibody against caspase-3, an executioner of apoptosis, in patients with systemic sclerosis..Rheumatol Int 30(7): 871-878, 2010
Yoshizaki A, Sato S:Olopatadine hydrochloride inhibits scratching behavior induced by a proteinase-activated receptor 2 agonist in mice.J Dermatol Sci 56(2): 136-139, 2009
Iwata Y, Yoshizaki A, Komura K, Shimizu K, Ogawa F, Hara T, Muroi E, Bae SJ, Takenaka M, Yukami T, Hasegawa M, Fujimoto M, Tomita Y, Tedder TF, Sato S:CD19, a response regulator of B lymphocytes, regulates wound healing through hyaluronan-induced TLR4 signaling.Am J Pathol 175(2): 649-660, 2009
Akiyama Y, Ogawa F, Iwata Y, Komura K, Hara T, Muroi E, Bae SJ, Takenaka M, Shimizu K, Hasegawa M, Fujimoto M, Sato S:Autoantibody against activating transcription factor-2 in patients with systemic sclerosis.Clin Exp Rheumatol 27(5): 751-757, 2009
Yanaba K, Muroi E, Yoshizaki A, Hara T, Ogawa F, Shimizu K, Yozaki M, Hasegawa M, Fujimoto M, Takehara K, Sato S:Serum CXCL16 concentrations correlate with the extent of skin sclerosis in patients with systemic sclerosis.J Rheumatol 36(9): 1917-1923, 2009
Yanaba K, Yoshizaki A, Muroi E, Hara T, Ogawa F, Usui A, Hasegawa M, Fujimoto M, Takehara K, Sato S:Elevated circulating TWEAK levels in systemic sclerosis: Association with lower frequency of pulmonary fibrosis..J Rheumatol 36(8): 1657-1662, 2009
Komura K, Iwata Y, Ogawa F, Yoshizaki A, Yamaoka T, Akiyama Y, Hara T, Hasegawa M, Fujimoto M, Sato S:Low zone tolerance requires ICAM-1 expression to limit contact hypersensitivity elicitation.J Invest Dermatol 129(11): 2661-2667, 2009
Ogawa A, Yoshizaki A, Yanaba K, Ogawa F, Hara T, Muroi E, Takenaka M, Shimizu K, Hasegawa M, Fujimoto M, Tedder TF, Sato S:The differential role of L-selectin and ICAM-1 in Th1-type and Th2-type contact hypersensitivity.J Invest Dermatol 130(6): 1558-1570, 2010
Yoshizaki A, Nakayama T, Naito S, Sekine I.:Expression patterns of pngiopoietin-1, -2, and Tie-2 receptor in ulcerative colitis support involvement of the angiopoietin/Tie pathway in the progression of ulcerative colitis..Dig Dis Sci: Dec 3, 2008
Yoshizaki A, Kawakami A, Aramaki T, Ida H, Eguchi K.:Preferential recovery by an intensive initial therapy from hemophagocytic syndrome complicated with adult onset Still;s disease presenting as agranulocytosis and hypercytokinemia..Clin Exp Rheumatol 26(2): 383, 2008
Chularojmontri L, Ihara Y, Muroi E, Goto S, Kondo T, Suvara K:Cytoprotective role of phyllanthus urinaria L. and Glutathione-S transferase Pi in doxorubicin-induced toxicity in H9c2 cells.J Med Assoc Thai 92(3): 1-9, 2009
Nakamura H, Kamiya-Matsumoto K, Kawakami A, Ida H, Hayashi T, Sato S, Kamihira S, Eguchi K:A case of cold agglutinin disease in the course of treatment for polymyalgia rheumatica.Modern Rheumatology 19(4): 427-430, 2009
Ishii T, Fujita T, Matsushita T, Yanaba K, Hasegawa M, Nakashima H, Ogawa F, Shimizu K, Takehara K, Tedder TF, Sato S, Fujimoto M:Establishment of experimental eosinophilic vasculitis by IgE-mediated cutaneous reverse passive arthus reaction..Am J Pathol 174(6): 2225-2233, 2009
Iwata Y, Yoshizaki A, Ogawa F, Komura K, Hara T, Muroi E, Takenaka M, Shimizu K, Hasegawa M, Fujimoto M, Takehara K, Sato S.:Increased serum pentraxin 3 in patients with systemic sclerosis..J Rheumatol 36(5): 976-983, 2009
Mugii N, Hasegawa M, Hamaguchi Y, Tanaka C, Kaji K, Komura K, Ueda-Hayakawa I, Horie S,Ikuta M, Tachino K, Ogawa F, Sato S, Fujimoto M and Takehara K:Reduced red blood cell velocity in nail-fold capillaries as a sensitive and specific indicator of microcirculation injury in systemic sclerosis..Rheumatology 48: 696-703, 2009
Hara T, Ogawa F, Yanaba K, Iwata Y, Muroi E, Komura K, Takenaka M, Shimizu K, Hasegawa M, Fujimoto M, Sato S:Elevated serum concentrations of polymorphonuclear neutrophilic leukocyte elastase in systemic sclerosis: association with pulmonary fibrosis..J Rheumatol 36(1):99-105, 2009
Yamaoka T, Ogwa F, Muroi E, Hara T, Komura K, Iwata Y, Takenaka M, Shimizu K, Hasegawa M, Fujimoto, M, Sato S:Autoantibody against a protease domain of caspase-8 in patients with systemic sclerosis..Clin Exp Rheumatol 26(6): 998-1004, 2008
Kuwatsuka Y, Ogawa F, Iwata Y, Komura K, Muroi E, Hara T, Takenaka M, Shimizu K, Hasegawa M, Fujimoto M, Sato S:Decreased levels of autoantibody against histone deacetylase 3 in patients with systemic sclerosis..Autoimmunity 42(2): 120-125, 2009
Hasegawa M, Sato S:The roles of chemokines in leukocyte recruitment and fibrosis in systemic sclerosis..Frontiers in bioscience 13: 3637-3647, 2008
Hamaguchi Y, Fujimoto M, Matsushita T, Hasegawa M, Takehara K, Sato S:Elevated Serum Insulin-like Growth Factor (IGF-1) and IGF Binding Protein-3 Levels in Patients with Systemic Sclerosis: Possible Role in Development of Fibrosis..J Rheumatol 35(12): 2363-2371, 2008
Iwata Y, Sato S, Murase Y, Iijima A, Hayashi K, Murakami S, Usuda T:Five cases of necrotizing fasciitis: Lack of skin inflammatory signs as a clinical clue for the fulminant type..J Dermatol 35(11): 719-725, 2008
Shimizu K, Ogawa F, Akiyama Y, Sato SMuroi E, Yoshizaki A, Iwata Y, Komura K, Bae SJ, Sato S:Increased serum levels of N(epsilon)-(hexanoyl)lysine, a new marker of oxidative stress, in systemic sclerosis..J Rheumatol 35(11): 2214-2219, 2008
Hikami K, Ehara Y, Hasegawa M, Fujimoto M, Matsushita M, Oka T, Takehara K, Sato S, Tokunaga K, Tsuchiya N:Association of IL-10 receptor 2 (IL10RB) SNP with systemic sclerosis..Biochem Biophys Res Commun 373(3): 403-407, 2008
Nakamura H, Tateishi S, Kawakami A, Ida H, Fukuda T, Sasaki M, Koide Y, Ashizawa N, Seto S, Hayashi T, Sato S, Eguchi K:A case of mixed connective tissue disease complicated with hypertrophic obstructive cardiomyopathy..Rheumatol Int 28(12): 1273-1275, 2008
Matsushita T, Hasegawa M, Shirasaki F, Fujimoto M, Yamazaki H, Sato S, Takehara K:A case of acute cutaneous graft-versus-host disease mimicking psoriasis vulgaris..Dermatology 216(1): 64-67, 2008
Matsushita T, Fujimoto M, Echigo T, Matsushita Y, Shimada Y, Hasegawa M, Takehara K, Sato S:Elevated serum levels of APRIL, but not BAFF, in patients with atopic dermatitis..Exp Dermatol 17(3): 197-202, 2008
Hamaguchi Y, Hasegawa M, Fujimoto M, Matsushita T, Komura K, Kaji K, Kondo M, Nishijima C, Hayakawa I, Ogawa F, Kuwana M, Takehara K, Sato S:The clinical relegance of serum antinuclear antibodies in Japanese patients with sysntemic sclerosis..Br J Dermatol 158(3): 487-495, 2008
Komura K, Manabu F, Yanaba K, Matsushita T, Matsushita Y, Horikawa M, Ogawa F, Shimizu K, Hasegawa M, Takehara K, Sato S:Blockade of CD40-CD40 ligand interactions attenuates skin fibrosis and autoimmunity in the tight-skin mouse..Ann Rheum Dis 67(6): 867-872, 2008
Komura K, Yoshizaki A, Kodera M, Iwata Y, Ogawa F, Shimizu K, Wayaku T, Yukami T, Murata M, Hasegawa M, Fujimoto M, Takehara K, Sato S:Increased Serum Soluble OX40 in Patients with Systemic Sclerosis..J Rheumatol 35(12): 2359-2362, 2008
Komura K, Yanaba K, Horikawa M, Ogawa F, Fujimoto M, Tedder TF, Sato S:CD19 regulates the development of bleomycin-induced pulmonary fibrosis in a mouse model..Arthritis Rheum 58(11): 3574-3584, 2008
Ogawa F, Shimizu K, Hara T, Muroi E, Hasegawa M, Takehara K, Sato S:Serum levels of heat shock protein 70, a biomarker of cellular stress, are elevated in patients with systemic sclerosis: association with fibrosis and vascular damage..Clin Exp Rheumatol 26(4):659-662, 2008
Yoshizaki A, Komura K, Iwata Y, Ogawa F, Hara T, Muroi E, Takenaka M, Shimizu K, Hasegawa M, Fujimoto M, Sato S:Clinical significance of serum HMGB-1 and sRAGE levels in systemic sclerosis: association with disease severity..J Clin Immunol 29(2): 180-189, 2009
Yoshizaki A, Iwata Y, Komura K, Hara T, Ogawa F, Muroi E, Takenaka M, Shimizu K, Hasegawa M, Fujimoto M, Sato S:Clinical Significance of Serum Hyaluronan Levels in Systemic Sclerosis: Association with Disease Severity..J Rheumatol 35(9):1825-1829, 2008
Shimizu K, Ogawa F, Thiele JJ, Lee JB, Bae SangJae, Sato S:Increased levels of urinary nitrite and nitrotyrosine in Yusho victims 40 years after accidental poisoning with polychlorinated biphenyls in Nagasaki, Japan..J Appl Toxicol 28(8): 1040-1044, 2008
Tomimura S, Ogawa F, Iwata Y, Komura K, Hara T, Muori E, Takenaka M, Shimizu K, Hasegawa M, Fujimoto M, Sato S:Autoantibodies against matrix metalloproteinase-1 in patinets with localized scleroderma..J Dermatol Sci 52(1): 47-54, 2008
Shimizu K, Bae SJ, Hara T, Iwata Y, Yamaoka T, Komura K, Muoi E, Takenaka M, Ogawa F, Sato S:Involvement of gaseous low molecular monoxides in the cutaneous reverse passive Arthus reaction: cytoprotective action of carbon monoxide..Clin Exp Immnuol 153(2): 245-257, 2008
Muroi E, Ogawa F, Shimizu K, Komura K, Hasegawa M, Fujimoto M, Sato S:Elevation of serum lymphotactin levels in patients with systemic sclerosis..J Rheumatol 35(5):834-838, 2008
Saito Y, Hasegawa M, Fujimoto M, Matsushita T, Horikawa M, Takenaka M, Ogawa F, Sugama J, Steeber DA, Sato S, Takehara K:The Loss of MCP-1 attenuates cutaneous ischemia-reperfusion injury in a mouse model of pressure ulcer..J Invest Dermatol 128(7): 1838-1851, 2008
Murata M, Fujimoto M, Matsushita T, Hamaguchi Y, Hasegawa M, Takehara K, Komura K, Sato S:Clinical association of serum interleukin-17 levels in systemic sclerosis: Is systemic sclerosis a Th17 disease?.J Dermatol Sci 50(3): 240-242, 2008
Yoshizaki A, Iwata Y, Komura K, Ogawa F, Hara T, Muroi E, Takenaka M, Shimizu K, Hasegawa M, Fujimoto M, Tedder TF, Sato S:CD19 Regulates Skin and Lung Fibrosis via TLR Signaling in a Bleomycin-Induced Scleroderma Model..Am J Pathol 172(6): 1650-1663, 2008
Hara T, Ogawa F, Muroi E, Komura K, Takenaka M, Hasegawa M, Fujimoto M, Sato S:Anti-p53 autoantibody in systemic sclerosis: association with limited cutaneous systemic sclerosis..J Rheumatol 35(3): 451-457, 2008
Komura K, Yanaba K, Ogawa F, Shimizu K, Takehara K, Sato S:Elevation of IgG levels is a serological indicator for pulmonary fibrosis in systemic sclerosis with anti-topoisomerase I antibodies and those with anticentromere antibody..Clin Exp Dermatol 33(3): 329-332, 2008
Iwata Y, Komura K, Kodera M, Usuda T, Yokoyama Y, Hara T, Muroi E, Ogawa F, Takenaka M, Sato S:Correlation of IgE autoantibody to BP180 with a severe form of bullous pemphigoid..Arch Dermatol 144(1): 41-48, 2008
Komura K, Fujimoto M, Hasegawa M, Ogawa F, Hra T, Muroi E, Takehara K, Sato S:Increased serum interleukin 23 in patients with systemic sclerosis.J Rheumatol 35(1): 120-125, 2008
HOME
前のページへ